Cell-Free Culture Supernatant of Bifidobacterium breve CNCM I-4035 Decreases Pro-Inflammatory Cytokines in Human Dendritic Cells Challenged with Salmonella typhi through TLR Activation
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Dendritic cells (DCs) constitute the first point of contact between gut commensals and our immune system. Despite growing evidence of the immunomodulatory effects of probiotics, the interactions between the cells of the intestinal immune system and bacteria remain largely unknown. Indeed,, the aim of this work was to determine whether the probiotic Bifidobacterium breve CNCM I-4035 and its cell-free culture supernatant (CFS) have immunomodulatory effects in human intestinal-like dendritic cells (DCs) and how they respond to the pathogenic bacterium Salmonella enterica serovar Typhi, and also to elucidate the molecular mechanisms involved in these interactions. Human DCs were directly challenged with B. breve/CFS, S. typhi or a combination of these stimuli for 4 h. The expression pattern of genes involved in Toll-like receptor (TLR) signaling pathway and cytokine secretion was analyzed. CFS decreased pro-inflammatory cytokines and chemokines in human intestinal DCs challenged with S. typhi. In contrast, the B. breve CNCM I-4035 probiotic strain was a potent inducer of the pro-inflammatory cytokines and chemokines tested, i.e., TNF-α, IL-8 and RANTES, as well as anti-inflammatory cytokines including IL-10. CFS restored TGF-β levels in the presence of Salmonella. Live B.breve and its supernatant enhanced innate immune responses by the activation of TLR signaling pathway. These treatments upregulated TLR9 gene transcription. In addition, CFS was a more potent inducer of TLR9 expression than the probiotic bacteria in the presence of S. typhi. Expression levels of CASP8 and IRAK4 were also increased by CFS, and both treatments induced TOLLIP gene expression. Our results indicate that the probiotic strain B. breve CNCM I-4035 affects the intestinal immune response, whereas its supernatant exerts anti-inflammatory effects mediated by DCs. This supernatant may protect immune system from highly infectious agents such as Salmonella typhi and can down-regulate pro-inflammatory pathways.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Probiotic use in clinical practice: what are the risks?
Boyle, R. J., Robins-Browne, R. M., & Tang, M. L. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.6.1256 · Cited by 776
The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review
Moayyedi, P., Ford, A. C., Talley, N. J., Cremonini, F., Foxx-Orenstein, A. E., Brandt, L. J., & Quigley, E. M. M. (2010) · Gut · doi:10.1136/gut.2008.167270 · Cited by 728 · cited 1×
“activity [10,11] and for reducing irritable bowel symptoms [12] and increasing the relapse time for some inflammatory bowel”
BackgroundYan, F., & Polk, D. B. (2011) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e32834baa4d · Cited by 447
Safety of probiotics: translocation and infection: Nutrition Reviews©, Vol. 66, No. 4
Liong, M.-T. (2008) · Nutrition Reviews · doi:10.1111/j.1753-4887.2008.00024.x · Cited by 265 · cited 1×
“activity [10,11] and for reducing irritable bowel symptoms [12] and increasing the relapse time for some inflammatory bowel”
BackgroundVoltan, S., Castagliuolo, I., Elli, M., Longo, S., Brun, P., D'Incà, R., Porzionato, A., Macchi, V., Palù, G., Sturniolo, G. C., et al. (2007) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00079-07 · Cited by 96 · cited 1×
“to activate an innate immune response [48–51] and provide”
Background
Cited by
Odamaki, T., Kato, K., Sugahara, H., Hashikura, N., Takahashi, S., Xiao, J.-Z., Abe, F., & Osawa, R. (2016) · BMC Microbiology · doi:10.1186/s12866-016-0708-5 · Cited by 1,521
The Impact of Food Bioactives on Health
(2015) · Springer eBooks · doi:10.1007/978-3-319-16104-4 · Cited by 805
Role of intestinal microbiota and metabolites on gut homeostasis and human diseases
Lin, L., & Zhang, J. (2017) · BMC Immunology · doi:10.1186/s12865-016-0187-3 · Cited by 731
“DCs, constituting the first point of contact between gut commensals and mammalian immune system [9], are central to harmonizing the host tolerance (to selfantigens) with host immunity (to pathogens) in the peripheral lymphoid tissues [10].”
BackgroundGut microbiota modulation: a novel strategy for prevention and treatment of colorectal cancer
Fong, W., Li, Q., & Yu, J. (2020) · Oncogene · doi:10.1038/s41388-020-1341-1 · Cited by 613
Plaza-Díaz, J., Ruiz-Ojeda, F., Vilchez-Padial, L., & Gil, A. (2017) · Nutrients · doi:10.3390/nu9060555 · Cited by 423
Self-citationSaez-Lara, M. J., Gomez-Llorente, C., Plaza-Diaz, J., & Gil, A. (2015) · BioMed Research International · doi:10.1155/2015/505878 · Cited by 388
Self-citationArena, M. P., Silvain, A., Normanno, G., Grieco, F., Drider, D., Spano, G., & Fiocco, D. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00464 · Cited by 299
De Marco, S., Sichetti, M., Muradyan, D., Piccioni, M., Traina, G., Pagiotti, R., & Pietrella, D. (2018) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2018/1756308 · Cited by 297
“In particular, CFS decreased proinflammatory cytokines and chemokines in human intestinal dendritic cells challenged with Salmonella enterica serovar Typhi [51].”
BackgroundPlaza-Diaz, J., Gomez-Llorente, C., Campaña-Martin, L., Matencio, E., Ortuño, I., Martínez-Silla, R., Gomez-Gallego, C., Periago, M. J., Ros, G., Chenoll, E., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078111 · Cited by 44
“rhamnosus CNCM I-4036 inhibited the production of pro-inflammatory cytokines and chemokines by human intestinal dendritic cells challenged with pathogenic bacteria and that such an effect seems to be mediated through a decreased expression of toll-like receptor (TLR)-1, TLR-5 and TLR-9 [32,33].”
Background
Metadata
- Authors
- Bermudez-Brito, M., Muñoz-Quezada, S., Gomez-Llorente, C., Matencio, E., Bernal, M. J., Romero, F., & Gil, A.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-03-12
- Volume
- 8
- Issue
- 3
- Pages
- e59370
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2022577922
- Cited by
- 114
- References
- 5
- FWCI
- 14.17
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.